CCL2/CCR2 signaling in cancer pathogenesis

by Qiongyu Hao, Jaydutt V. Vadgama, Piwen Wang
Published 2020-05-01

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

by Wei Cao, Jieqing Li, Qiongyu Hao, Jaydutt V Vadgama, Yong Wu
Published 2019-02-01

The role of PPM1D in cancer and advances in studies of its inhibitors

by Wenhong Deng, Jieqing Li, Kimberly Dorrah, Denise Jimenez-Tapia, Brando Arriaga, Qiongyu Hao, Wei Cao, Zhaoxia Gao, Jay Vadgama, Yong Wu
Published 2020-05-01

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA

by Qiongyu Hao, Piwen Wang, Pranabananda Dutta, Seyung Chung, Qun Li, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Qing Geng, Katrina Schrode, Magda Shaheen, Ke Wu, Donghui Zhu, Qiao-Hong Chen, Guanglin Chen, Yahya Elshimali, Jay Vadgama, Yong Wu
Published 2020-12-01